True Leaf Medicine International

True Leaf in its $10.5 million convertible security financing


True Leaf Medicine International Ltd.


$10.5 million


Capital Markets

Date Closed

February 2019

Lead Office


On February 21, 2019, True Leaf Medicine International Ltd. ("True Leaf") announced that it closed a convertible security financing for gross proceeds of $4.5 million with an entity managed by The Lind Partners.  Under the funding agreement, True Leaf and the investor may agree for the investor to advance up to an additional $6 million in gross proceeds to True Leaf in exchange for a second convertible security on the same terms.

True Leaf Medicine International Ltd., headquartered in Vancouver, Canada, is a leading global cannabis and hemp wellness brand for pets.

The Lind Partners is a New York-based institutional fund manager focused on small- and mid-cap companies listed in the United States, Canada, Australia, and the UK focused on high-growth sectors such as mining, oil and gas, biotech, and technology.

Osler, Hoskin & Harcourt LLP represented True Leaf Medicine with a team consisting of Trevor Scott, Shahir Guindi, Jason Comerford, Patrick Sullivan (Corporate) and Martha Martindale (Financial Services).